[1]. RNA sequencing and target long-read sequencing reveal an intronic transposon insertion causing aberrant splicing
JOURNAL OF HUMAN GENETICS [巻]69 [号]2 [頁]91 -99 （2024年） [査読] 有
[DOI] [2]. Utility of
ASNS gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL
EPIGENETICS [巻]18 [号]1 [頁]2268814 （2023年） [査読] 有
[DOI] [3]. Safety and efficacy of post-haematopoietic cell transplantation maintenance therapy with blinatumomab for relapsed/refractory CD19-positive B-cell acute lymphoblastic leukaemia: protocol for a phase I-II, multicentre, non-blinded, non-controlled trial.
BMJ open [巻]13 [号]4 [頁]e070051 （2023年） [査読] 有
[DOI] [4]. Characterization of KMT2A::MATR3 fusion in a patient with acute lymphoblastic leukemia and monitoring of minimal residual disease by nanoplate digital PCR.
Pediatric blood & cancer [巻]70 [号]4 [頁]e30120 （2023年） [査読] 有
[DOI] [5]. Impact of asparaginase discontinuation on outcomes of children with acute lymphoblastic leukaemia receiving the Japan Association of Childhood Leukaemia Study ALL-02 protocol.
British journal of haematology [巻]201 [号]6 [頁]1200 -1208 （2023年） [査読] 有
[DOI]